S'abonner

Connection

Risk of Aspiration Due to Dysphagia - TIGLUTIK (riluzole) - ALS Treatment

Risk of Aspiration Due to Dysphagia - TIGLUTIK (riluzole) - ALS Treatment

Aspiration pneumonia can be dangerous if left untreated. It is one of the leading causes of hospitalization and the second leading cause of death in ALS.

Incidence, risk factors, and sequelae of dysphagia mediated aspiration following lung transplantation - The Journal of Heart and Lung Transplantation

The assessment of dysphagia after stroke: state of the art and future directions - The Lancet Neurology

TIGLUTIK is for People Who Have Difficulty Swallowing - TIGLUTIK (riluzole) - ALS Treatment

J, Free Full-Text

Frontiers Administration of Riluzole Oral Suspension During the Different Stages of Amyotrophic Lateral Sclerosis

Riluzole for the treatment of amyotrophic lateral sclerosis

Dysphagia as the Initial Presenting Symptom of Amyotrophic Lateral Sclerosis

Surgical Treatment of Dysphagia - ScienceDirect

J, Free Full-Text

Riluzole Oral Suspension: Bioavailability Following Percutaneous Gastrostomy Tube-modeled Administration Versus Direct Oral Administration - ScienceDirect